| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5898800 | Diabetes Research and Clinical Practice | 2016 | 36 Pages | 
Abstract
												A moderate hypoglycaemic effect of probiotics, with a significantly lower FBG was noted. Findings on HbA1c, anti-inflammatory and anti-oxidative effects of probiotics in the clinical setting, however, remain inconsistent. The findings imply the need for well-designed clinical studies to further assess the potential beneficial effects of probiotics in management of T2DM.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Endocrinology
												
											Authors
												Syamimi Samah, Kalavathy Ramasamy, Siong Meng Lim, Chin Fen Neoh, 
											